We’ve cut our fair value estimates on these stocks by more than 10%, but we still like the fundamentals of these companies--at the right price.
These Gold-rated intermediate-term bond funds can provide ballast to a portfolio no matter your life stage.
In a nod to March Madness, here’s our list of elite stocks--and they’re on sale, too.
We expect these high-yielders to sustain their dividends in the future. Plus, they’re cheap.
These narrow- and wide-moat names are beating the market this year yet remain undervalued according to our metrics.
These Gold-rated mutual funds and ETFs provide exposure to the strongest-performing part of the equity market this year.
These wide-moat, low uncertainty names may be slightly overpriced today, but they should be on quality seekers’ watchlists.
These wide- and narrow-moat international stocks are trading well below our fair value estimates.
These stocks enjoyed fair value increases in February. But are they worth buying today?